<!DOCTYPE html><html><head><title>Stroke and stroke rehabilitation: percentage of patients aged 18 years and older with the diagnosis of ischemic stroke whose time from symptom onset to arrival is less than 3 hours who were considered for tissue plasminogen activator (t-PA) administration.</title><link rel="stylesheet" type="text/css" href="style.css"></head><body><div class='section'>
<h2>General
</h2>
<div class='field field_text'>
<h3>
Title
</h3>
<div class='FieldValue'>
<div class="content_title">Stroke and stroke rehabilitation: percentage of patients aged 18 years and older with the diagnosis of ischemic stroke whose time from symptom onset to arrival is less than 3 hours who were considered for tissue plasminogen activator (t-PA) administration.</div>
</div>

</div>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>American Academy of Neurology, American College of Radiology, Physician Consortium for Performance Improvement®, National Committee for Quality Assurance. Stroke and stroke rehabilitation physician performance measurement set. Chicago (IL): American Medical Association (AMA), National Committee for Quality Assurance (NCQA); 2009 Feb. 20 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Measure Domain
</h2>
<div class='field field_picklist-one'>
<h3>
Primary Measure Domain
</h3>
<div class='FieldValue'>
Process<div class="content_special_handling"><p>The validity of measures depends on how they are built. By examining the key building blocks of a measure, you can assess its validity for your purpose. For more information, visit the <a href="/selecting-and-using/validity.aspx">Measure Validity</a> page.<p/></div>
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Secondary Measure Domain
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>

</div>
<div class='section'>
<h2>Brief Abstract
</h2>
<div class='field field_text'>
<h3>
Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure is used to assess the percentage of patients aged 18 years and older with the diagnosis of ischemic stroke whose time from symptom onset to arrival is less than 3 hours who were considered for tissue plasminogen activator (t-PA) administration.</p>
<p>To promote a comprehensive approach to performance improvement, the Stroke and Stroke Rehabilitation Measurement Set is intended for use in its entirety when measuring clinical quality in the care of eligible patients. Full implementation of this measurement set for patients with a diagnosis of ischemic stroke or transient ischemic attack (TIA) should always include the Physician Consortium for Performance Improvement&#174; measure, <a href="/content.aspx?id=14298" title="Measure Summary">Radiology: Stenosis Measurement in Carotid Imaging Reports</a>.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Rationale
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Patients who arrive at the hospital within 3 hours of stroke symptom onset should be considered for tissue plasminogen activator (t-PA) therapy.*</p>

<p class="Note">*The following clinical recommendation statements are quoted <u>verbatim</u> from the referenced clinical guidelines and represent the evidence base for the measure:</p>

<p class="Note">We recommend administration of IV t-PA in a dose of 0.9 mg/kg (maximum of 90 mg), with 10% of the total dose given as an initial bolus and the remainder infused over 60 min for eligible patients, provided that treatment is initiated within 3 h of clearly defined symptom onset. We recommend strict adherence to eligibility criteria for the use of IV t-PA based on the NINDS trial protocol. (Inclusion Criteria: Age greater than or equal to 18 years, clinical diagnosis of stroke with a clinically meaningful neurologic deficit, clearly defined time of onset of less than 180 min before treatment, and a baseline CT showing no evidence of intracranial hemorrhage. (American College of Chest Physicians [ACCP])</p>

<p class="Note">Intravenous rtPA (0.9 mg/kg, maximum dose 90 mg) is strongly recommended for carefully selected patients who can be treated within 3 hours of onset of ischemic stroke. (American Stroke Association [ASA])</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Primary Clinical Component
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Ischemic stroke; tissue plasminogen activator (t-PA)</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>All patients aged 18 years and older with the diagnosis of ischemic stroke whose time from symptom onset to arrival is less than 3 hours</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Patients from the denominator who were considered for tissue plasminogen activator (t-PA) administration (given t-PA or documented reasons for patient not being a candidate for therapy)</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Evidence Supporting the Measure
</h2>
<div class='field field_picklist-choice'>
<h3>
Evidence Supporting the Criterion of Quality
</h3>
<div class='FieldValue'>
A clinical practice guideline or other peer-reviewed synthesis of the clinical evidence
</div>

</div>

</div>
<div class='section'>
<h2>Evidence Supporting Need for the Measure
</h2>
<div class='field field_picklist-choice'>
<h3>
Need for the Measure
</h3>
<div class='FieldValue'>
Use of this measure to improve performance
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence Supporting Need for the Measure
</h3>
<div class='FieldValue'>
<table><tr><td>McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA. The quality of health care delivered to adults in the United States. N Engl J Med. 2003 Jun 26;348(26):2635-45. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12826639" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Reeves MJ, Arora S, Broderick JP, Frankel M, Heinrich JP, Hickenbottom S, Karp H, LaBresh KA, Malarcher A, Mensah G, Moomaw CJ, Schwamm L, Weiss P, Paul Coverdell Prototype Registries Writing Group. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke. 2005 Jun;36(6):1232-40. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15890989" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P. Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006 Feb 14;113(6):e85-151. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16407573" target="_blank">PubMed</a></td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>State of Use of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
State of Use
</h3>
<div class='FieldValue'>
Current routine use
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Current Use
</h3>
<div class='FieldValue'>
Internal quality improvement
</div>
<div class='FieldValue'>
National reporting
</div>

</div>

</div>
<div class='section'>
<h2>Application of Measure in its Current Use
</h2>
<div class='field field_picklist-choice'>
<h3>
Care Setting
</h3>
<div class='FieldValue'>
Hospitals
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Professionals Responsible for Health Care
</h3>
<div class='FieldValue'>
Advanced Practice Nurses
</div>
<div class='FieldValue'>
Physician Assistants
</div>
<div class='FieldValue'>
Physicians
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Lowest Level of Health Care Delivery Addressed
</h3>
<div class='FieldValue'>
Individual Clinicians
</div>

</div>
<div class='field field_text'>
<h3>
Target Population Age
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Age greater than or equal to 18 years</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Target Population Gender
</h3>
<div class='FieldValue'>
Either male or female
</div>

</div>
<div class='field field_text'>
<h3>
Stratification by Vulnerable Populations
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Characteristics of the Primary Clinical Component
</h2>
<div class='field field_text'>
<h3>
Incidence/Prevalence
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Association with Vulnerable Populations
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Burden of Illness
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Utilization
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Costs
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Institute of Medicine (IOM) Healthcare Quality Report Categories
</h2>
<div class='field field_picklist-choice'>
<h3>
IOM Care Need
</h3>
<div class='FieldValue'>
Getting Better
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
IOM Domain
</h3>
<div class='FieldValue'>
Effectiveness
</div>

</div>

</div>
<div class='section'>
<h2>Data Collection for the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
Case Finding
</h3>
<div class='FieldValue'>
Users of care only
</div>

</div>
<div class='field field_text'>
<h3>
Description of Case Finding
</h3>
<div class='FieldValue'>
<div class="content_para"><p>All patients aged 18 years and older with the diagnosis of ischemic stroke whose time from symptom onset to arrival is less than 3 hours</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Denominator Sampling Frame
</h3>
<div class='FieldValue'>
Patients associated with provider
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
All patients aged 18 years and older with the diagnosis of ischemic stroke whose time from symptom onset to arrival is less than 3 hours</p>

<p><strong>Exclusions</strong><br />
None</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Relationship of Denominator to Numerator
</h3>
<div class='FieldValue'>
All cases in the denominator are equally eligible to appear in the numerator
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Denominator (Index) Event
</h3>
<div class='FieldValue'>
Clinical Condition
</div>
<div class='FieldValue'>
Encounter
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Denominator Time Window
</h3>
<div class='FieldValue'>
Time window is a single point in time
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
Patients who were considered for tissue plasminogen activator (t-PA) administration (given t-PA or documented reasons for patient not being a candidate for therapy)</p>

<p><strong>Exclusions</strong><br />
None</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Measure Results Under Control of Health Care Professionals, Organizations and/or Policymakers
</h3>
<div class='FieldValue'>
The measure results are somewhat or substantially under the control of the health care professionals, organizations and/or policymakers to whom the measure applies.
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Numerator Time Window
</h3>
<div class='FieldValue'>
Encounter or point in time
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Data Source
</h3>
<div class='FieldValue'>
Administrative data 
</div>
<div class='FieldValue'>
Medical record
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Level of Determination of Quality
</h3>
<div class='FieldValue'>
Individual Case
</div>

</div>
<div class='field field_text'>
<h3>
Pre-existing Instrument Used
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Computation of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
Scoring
</h3>
<div class='FieldValue'>
Rate
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Interpretation of Score
</h3>
<div class='FieldValue'>
Better quality is associated with a higher score
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Allowance for Patient Factors
</h3>
<div class='FieldValue'>
Unspecified
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Standard of Comparison
</h3>
<div class='FieldValue'>
Internal time comparison
</div>

</div>

</div>
<div class='section'>
<h2>Evaluation of Measure Properties
</h2>
<div class='field field_text'>
<h3>
Extent of Measure Testing
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Identifying Information
</h2>
<div class='field field_text'>
<h3>
Original Title
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Measure #4: tissue plasminogen activator (t-PA) considered.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Collection Name
</h3>
<div class='FieldValue'>
The Physician Consortium for Performance Improvement&#174; Measurement Sets
</div>

</div>
<div class='field field_text'>
<h3>
Measure Set Name
</h3>
<div class='FieldValue'>
Stroke and Stroke Rehabilitation Physician Performance Measurement Set
</div>

</div>
<div class='field field_orglist'>
<h3>
Submitter
</h3>
<div class='FieldValue'>
American Medical Association on behalf of the American Academy of Neurology, American College of Radiology, Physician Consortium for Performance Improvement®, and National Committee for Quality Assurance - Medical Specialty Society
</div>

</div>
<div class='field field_orglist-p'>
<h3>
Developer
</h3>
<div class='FieldValue'>
American Academy of Neurology - Medical Specialty Society
</div>
<div class='FieldValue'>
American College of Radiology - Medical Specialty Society
</div>
<div class='FieldValue'>
National Committee for Quality Assurance - Health Care Accreditation Organization
</div>
<div class='FieldValue'>
Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration
</div>

</div>
<div class='field field_text'>
<h3>
Funding Source(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Composition of the Group that Developed the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Joseph Drozda, Jr., MD (<em>Co-Chair</em>); Robert Holloway, MD, MPH (<em>Co-Chair</em>); David Seidenwurm, MD (<em>Co-Chair</em>); Chris Alexander, III, MD, FACP; John Barr, MD; Oscar Benavente, MD, FRCPC; Christopher Bever, Jr., MD, MBA; Thomas Bleck, MD FCCM; Ronald Gabel, MD; Judith Hinchey, MD; Irene Katzan, MD; Rahul K. Khare, MD; Michael Lev, MD; John McMahon, MD; Mark Morasch, MD, FACS; Suresh Mukherji, MD; Konrad C. Nau, MD; Sam J. W. Romeo, MD, MBA; Eric Russell, MD, FACR; Marilyn Rymer, MD; Ajay Sharma, MD; John Schneider, MD, PhD; Timothy Shephard, PhD; Michael A. Sloan, MD, MS; William D. Smucker, MD, CMD; Patrick Turski, MD, FACR; Linda Williams, MD; Richard Zorowitz, MD</p>

<p>Sarah Tonn, MPH, American Academy of Neurology</p>

<p>Sandra H. Bjork, RN, JD, American College of Radiology</p>

<p>Penelope Solis, JD, American Heart Association/American Stroke Association</p>

<p>Andrea Gelzer, MD, MS, FACP, Health Plan Representative</p>

<p>Mark Antman, DDS, MBA, American Medical Association; Karen S. Kmetik, PhD, American Medical Association; Beth Tapper, MA, American Medical Association; Samantha Tierney, MPH, American Medical Association</p>

<p>Rebecca A. Kresowik, Facilitator; Timothy F. Kresowik, MD, Facilitator</p>
</div>
</div>

</div>
<div class='field field_text'>
<h3>
Financial Disclosures/Other Potential Conflicts of Interest
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Conflicts, if any, are disclosed in accordance with the Physician Consortium for Performance Improvement&#174; conflict of interest policy.</p></div>
</div>

</div>
<div class='field field_orglist'>
<h3>
Endorser
</h3>
<div class='FieldValue'>
National Quality Forum - None
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Included in
</h3>
<div class='FieldValue'>
Ambulatory Care Quality Alliance
</div>

</div>
<div class='field field_text'>
<h3>
Adaptation
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure was harmonized to the extent possible with hospital level measures for stroke developed by The Joint Commission.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Parent Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_date'>
<h3>
Release Date
</h3>
<div class='FieldValue'>
2006 Sep
</div>

</div>
<div class='field field_date'>
<h3>
Revision Date
</h3>
<div class='FieldValue'>
2009 Feb
</div>

</div>
<div class='field field_text'>
<h3>
Measure Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the measure.</p>
<p>The Physician Consortium for Performance Improvement reaffirmed the currency of this measure in November 2010.</p></div>
</div>

</div>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>American Academy of Neurology, American College of Radiology, Physician Consortium for Performance Improvement®, National Committee for Quality Assurance. Stroke and stroke rehabilitation physician performance measurement set. Chicago (IL): American Medical Association (AMA), National Committee for Quality Assurance (NCQA); 2009 Feb. 20 p. </td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Availability
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The individual measure, "Measure #4: Tissue Plasminogen Activator (t-PA) Considered," is published in the "Stroke and Stroke Rehabilitation: Physician Performance Measurement Set."  This document and technical specifications are available in Portable Document Format (PDF) from the American Medical Association (AMA)-convened Physician Consortium for Performance Improvement® Web site: <a href="http://www.physicianconsortium.org" target="_blank" title="AMA Web site">www.physicianconsortium.org</a>.</p>

<p>For further information, please contact AMA staff by e-mail at <a href="mailto:cqi@ama-assn.org">cqi@ama-assn.org</a>.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
NQMC Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NQMC summary was completed by ECRI Institute on September 13, 2007. The information was verified by the measure developer on October 26, 2007. This NQMC summary was edited by ECRI Institute on September 28, 2009. The information was reaffirmed by the measure developer on November 17, 2010.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Copyright Statement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>&#169; Measures including specifications</p>

<p>&#169; 2005-6 American Medical Association and National Committee for Quality Assurance</p>
</div>
</div>

</div>

</div>
<div class='section'>
<h2>Disclaimer
</h2>
<div class='field field_text'>
<h3>
NQMC Disclaimer
</h3>
<div class='FieldValue'>
<p>The National Quality Measures Clearinghouse™ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.</p> 
<p>All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.</p> 
<p>Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the <a href="/help-and-about/summaries/inclusion-criteria">NQMC Inclusion Criteria</a>.</p> 
<p>NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding measure content are directed to contact the measure developer.</p>
</div>

</div>

</div>
</body></html>